HRTX
HERON THERAPEUTICS, INC. /DE/
-0.00 (-0.16%)0.32USD466K成交股數60.7M市值–本益比(近四季)0.4股價營收比+1.3%營收年增(近四季)2026-11-03下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 12 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 37.7M-3% | 34.7M-15% | 38.2M+16% | 37.2M+3% | 38.9M+12% | 40.8M+30% | 32.8M+3% | 36.0M+22% | 34.7M | 31.4M | 31.8M | 29.6M |
| 營業成本 | 11.6M | 10.6M | 11.9M | 9.9M | 8.5M | 10.2M | 9.5M | 10.5M | 8.4M | 18.2M | 20.2M | 16.9M |
| 毛利 | 26.1M-14% | 24.1M-21% | 26.3M+13% | 27.3M+7% | 30.4M+16% | 30.6M+131% | 23.4M+101% | 25.5M+100% | 26.2M | 13.2M | 11.6M | 12.8M |
| 毛利率 | 69.3% | 69.4% | 68.8% | 73.5% | 78.3% | 74.9% | 71.2% | 70.8% | 75.6% | 42.1% | 36.5% | 43.1% |
| 研發費用 | 2.7M | 2.4M | 3.5M | 2.9M | 2.3M | 3.2M | 4.5M | 4.4M | 4.6M | 9.3M | 13.2M | 8.8M |
| 銷售管理費用 | 11.3M | 12.1M | 14.0M | 14.5M | 12.7M | 12.1M | 12.4M | 13.9M | 15.0M | 15.9M | 19.6M | 15.8M |
| 營業利益 | −2.0M-165% | −4.8M-214% | −4.1M-8% | −1.6M-75% | 3.2M-166% | 4.2M-117% | −4.5M-89% | −6.4M-81% | −4.8M | −24.9M | −42.4M | −33.1M |
| 營業利益率 | -5.4% | -13.7% | -10.7% | -4.4% | 8.1% | 10.2% | -13.6% | -17.9% | -13.8% | -79.3% | -133.5% | -111.6% |
| 稅後淨利 | −5.5M-308% | −8.1M-350% | −17.5M+261% | −2.4M-74% | 2.6M-183% | 3.2M-113% | −4.8M-88% | −9.2M-72% | −3.2M | −25.0M | −42.1M | −32.8M |
| 淨利率 | -14.6% | -23.4% | -45.8% | -6.4% | 6.8% | 8.0% | -14.8% | -25.6% | -9.1% | -79.6% | -132.4% | -110.6% |
| 稀釋 EPS | -0.03-400% | -0.04-300% | -0.10+233% | -0.02-67% | 0.01-150% | 0.02-112% | -0.03-91% | -0.06-78% | -0.02 | -0.17 | -0.35 | -0.27 |
| 稀釋股數 | 190M | 190M | 170M | 154M | 197M | 152M | 153M | 152M | 151M | 145M | 120M | 119M |
資產負債表 期末餘額
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 20.7M | 26.1M | 43.1M | 16.5M | 19.3M | 25.8M | 25.7M | 18.4M | 20.5M | 34.9M | 13.5M | 27.1M |
| 應收帳款 | 89.6M | 83.7M | 81.0M | 79.9M | 78.7M | 78.9M | 67.0M | 73.7M | 65.3M | 63.8M | 76.7M | 51.4M |
| 存貨 | 90.6M | 92.5M | 70.0M | 73.0M | 56.9M | 53.2M | 46.0M | 42.9M | 42.5M | 42.0M | 44.6M | 52.1M |
| 總資產 | 252M | 246M | 249M | 232M | 236M | 233M | 221M | 218M | 218M | 229M | 201M | 221M |
| 有息負債 | – | – | – | – | – | – | – | – | – | – | – | – |
| 總負債 | 245M | 237M | 234M | 259M | 264M | 267M | 261M | 256M | 252M | 257M | 241M | 232M |
| 股東權益 | 6.9M | 9.1M | 14.9M | −27.3M | −28.5M | −33.7M | −40.0M | −37.9M | −33.8M | −27.8M | −39.3M | −11.4M |
| 負債比 | 97.3% | 96.3% | 94.0% | 111.7% | 112.1% | 114.4% | 118.1% | 117.4% | 115.5% | 112.1% | 119.5% | 105.2% |
| 淨現金(現金 − 有息負債) | – | – | – | – | – | – | – | – | – | – | – | – |
現金流量表 單季
| 科目 | 26Q2 | 26Q1 | 25Q3 | 25Q2 | 25Q1 | 24Q4 | 24Q3 | 24Q2 | 24Q1 | 23Q3 | 23Q2 | 23Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | −1.5M | – | – | −8.9M-7% | – | – | – | −9.5M | – | – | −24.9M |
| 資本支出 | – | 391K | – | – | 109K | – | – | – | – | – | – | 224K |
| 自由現金流 | – | −1.9M | – | – | −9.0M | – | – | – | – | – | – | −25.1M |
| 折舊攤銷 | – | 529K | – | – | 551K | – | – | – | 689K | – | – | 718K |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | – | – | – | – | – | – | – | – | – | – |
| 自由現金流率 | – | -5.6% | – | – | -23.1% | – | – | – | – | – | – | -84.8% |
營收拆解 2025 年度 10-K 的分部揭露 · 年增對前一年度
產品／服務2025 年度 · 155M
| CINVANTI | 96.8M | 62.5% | -3.3% |
|---|---|---|---|
| ZYNRELEF | 38.1M | 24.6% | +49.0% |
| Aponvie | 11.6M | 7.5% | +156.1% |
| SUSTOL | 8.5M | 5.5% | -39.9% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2025 | 155M | +7.4% | −20.0M | -12.9% | -0.12 | −27.9M |
| FY2024 | 144M | +13.6% | −14.0M | -9.7% | -0.09 | −24.2M |
| FY2023 | 127M | +18.0% | −111M | -87.4% | -0.80 | −60.3M |
| FY2022 | 108M | +24.7% | −182M | -169.0% | -1.67 | −149M |
| FY2021 | 86.3M | -2.6% | −221M | -255.9% | -2.24 | −206M |
| FY2020 | 88.6M | -39.3% | −227M | -256.4% | -2.50 | −192M |
| FY2019 | 146M | +88.4% | −205M | -140.3% | -2.50 | −132M |
| FY2018 | 77.5M | – | −179M | -230.8% | -2.44 | −201M |